Skip to main content
Search
Search
    Quick Search anywhere
    Quick search in Citations
Advanced Search
Skip main navigationClose Drawer MenuOpen Drawer Menu
Previous article
Next article
Review

Can we predict and prevent the postthrombotic syndrome?

Published Online:January 04, 2021https://doi.org/10.1024/0301-1526/a000932

Abstract

Summary: Postthrombotic syndrome (PTS) remains one of the major late complications of deep vein thrombosis (DVT) with a reported prevalence from 10 to 50%. Many factors were found to be related with the development and severity of PTS such as ipsilateral recurrent DVT, advanced age, obesity, ilio-femoral DVT and primary chronic venous disease presence. Some PTS prediction models have been proposed based on risk factor weight. However, it is still difficult to predict which patient with DVT will develop PTS and thus, the clinical application of these models remains limited. Among the identified problems the heterogeneity of the DVT patient population together with the variety of PTS clinical presentations and difficulties concerning PTS severity assessment should be mentioned. Difficulties on the implementation of the specific and objective PTS identification method have also the significant influence on the research focusing on PTS prevention modalities including risk factor modification, compression treatment, anticoagulation and invasive DVT treatment. In this review, the current approach and knowledge on PTS prediction and prevention are presented, including the conservative and invasive DVT treatment possibilities.

References

  • 1 ISTH Steering Committee for World Thrombosis Day. Thrombosis: a major contributor to the global disease burden. J Thromb Haemost. 2014;12:1580–90. First citation in articleCrossref Medline, Google Scholar

  • 2 Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D, Brecht JG, et al. VTE Impact Assessment Group in Europe (VITAE). Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost. 2007;98:756–64. First citation in articleCrossref Medline, Google Scholar

  • 3 Yusuf HR, Tsai J, Atrash HK, Boulet S, Grosse SD. Venous thromboembolism in adult hospitalizations in United States, 2007–2009. MMWR Morb Mortal Wkly Rep. 2012;61:401–4. First citation in articleMedline, Google Scholar

  • 4 Martinez C, Wallenhorst C, Teal S, Cohen AT, Peacock AJ. Incidence and risk factors of chronic thromboembolic pulmonary hypertension following venous thromboembolism, a population-based cohort study in England. Pulm Circ. 2018;8:2045894018791358. First citation in articleCrossref, Google Scholar

  • 5 Rabinovich A, Kahn SR. The postthrombotic syndrome: current evidence and future challenges. J Thromb Haemost. 2017;15:230–41. First citation in articleCrossref Medline, Google Scholar

  • 6 Kahn SR, Galanaud JP, Vedantham S, Ginsberg JS. Guidance for the prevention and treatment of the post-thrombotic syndrome. J Thromb Thrombolysis. 2016;41:144–53. First citation in articleCrossref Medline, Google Scholar

  • 7 Zhang Z, Song K, Yao Y, Jiang T, Pan P, Jiang Q. Incidence and risk factors for post-thrombotic syndrome in patients with deep vein thrombosis following total knee and hip arthroplasty. J Arthroplasty. 2019;34:560–3. First citation in articleCrossref Medline, Google Scholar

  • 8 van Rij AM, Hill G, Krysa J, Dutton S, Dickson R, Christie R, et al. Prospective study on natural history of deep vein thrombosis: early predictors of poor late outcomes. Ann Vasc Surg. 2013;27:924–31. First citation in articleCrossref Medline, Google Scholar

  • 9 Yamaki T, Hamahata A, Soejima K, Kono T, Nozaki M, Sakurai H. Factors predicting development of post-thrombotic syndrome in patients with a first episode of deep vein thrombosis: preliminary report. Eur J Vasc Endovasc Surg. 2011;41:126–33. First citation in articleCrossref Medline, Google Scholar

  • 10 Labropoulos N, Waggoner T, Sammis W, Samali S, Pappas P. The effect of venous thrombus location and extent on the development of post-thrombotic signs and symptoms. J Vasc Surg. 2008;48:407–12. First citation in articleCrossref Medline, Google Scholar

  • 11 Eklof B, Perrin M, Deils K, Rutheford R, Gloviczki P. The VEIN TERM transatlantic interdisciplinary consensus document. J Vasc Surg. 2009;49:498–501. First citation in articleCrossref Medline, Google Scholar

  • 12 Utne KK, Ghanima W, Foyn S, Kahn S, Sandset PM, Wik HS. Development and validation of a tool for patient reporting of symptoms and signs of the post-thrombotic syndrome. Thromb Haemost. 2016;115:361–7. First citation in articleCrossref Medline, Google Scholar

  • 13 Ginsberg JS, Turkstra F, Buller HR, MacKinnon B, Magier D, Hirsh J. Postthrombotic syndrome after hip or knee arthroplasty: a crosssectional study. Arch Intern Med. 2000;160:669–72. First citation in articleCrossref Medline, Google Scholar

  • 14 Jayaraj A, Meissner M. A comparison of Villalta-Prandoni scale and venous clinical severity score in the assessment of post thrombotic syndrome. Ann Vasc Surg. 2014;28:313–7. First citation in articleCrossref Medline, Google Scholar

  • 15 Kahn SR, Partsch H, Vedantham S, Prandoni P, Kearon C, on behalf of the Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization. J Thromb Haemost. 2009;7:879–83. First citation in articleCrossref Medline, Google Scholar

  • 16 Villalta S, Bagatella P, Piccioli A, Lensing AW, Prins MH, Prandoni P. Assessment of validity and reproducibility of a clinical scale for the post-thrombotic syndrome (abstract). Haemostasis. 1994;24:158a. First citation in articleGoogle Scholar

  • 17 Strijkers RH, Wittens CH, Kahn SR. Villalta scale: goals and limitations. Phlebology. 2012;27:130–5. First citation in articleCrossref Medline, Google Scholar

  • 18 Wik HS, Enden TR, Ghanima W, Engeseth M, Kahn SR, Sandset PM. Diagnostic scales for the post-thrombotic syndrome. Thromb Res. 2018;164:110–11. First citation in articleCrossref Medline, Google Scholar

  • 19 Engeseth M, Enden T, Sandset PM, Wik HS. Limitations of the Villalta scale in diagnosing post-thrombotic syndrome. Thromb Res. 2019;184:62–6. First citation in articleCrossref Medline, Google Scholar

  • 20 van der Velden SK, Shadid NH, Nelemans PJ, Sommer A. How specific are venous symptoms for diagnosis of chronic venous disease? Phlebology. 2014;29:580–6. First citation in articleCrossref Medline, Google Scholar

  • 21 Soosainathan A, Moore H, Gohel M, Davies A. Scoring systems for the post-thrombotic syndrome. J Vasc Surg. 2013;57:254–61. First citation in articleCrossref Medline, Google Scholar

  • 22 Kahn SR, Desmarais S, Ducruet T, Arsenault L, Ginsberg JS. Comparison of the Villalta and Ginsberg clinical scales to diagnose the post-thrombotic syndrome: correlation with patient-reported disease burden and venous valvular reflux. J Thromb Haemost. 2006;4:907–8. First citation in articleCrossref Medline, Google Scholar

  • 23 Brandjes DP, Buller HR, Heijboer H, Huisman MV, de Rijk M, Jagt H, et al. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet. 1997;349:759–62. First citation in articleCrossref Medline, Google Scholar

  • 24 Kolbach DN, Neumann HA, Prins MH. Definition of the postthrombotic syndrome, differences between existing classifications. Eur J Vasc Endovasc Surg. 2005;30:404–14. First citation in articleCrossref Medline, Google Scholar

  • 25 Widmer L, Stathelin H, Nissen CSd. Venen-, Arterien-, Krankheiten, koronaire Herzkrankhei bei berufstatigen. Bern: Verlag Hans Huber; 1981. First citation in articleGoogle Scholar

  • 26 Kahn SR. The post-thrombotic syndrome. Hematology Am Soc Hematol Educ Program. 2016;2016:413–8. First citation in articleCrossref Medline, Google Scholar

  • 27 Galanaud JP, Monreal M, Kahn SR. Predictors of the post-thrombotic syndrome and their effect on the therapeutic management of deep vein thrombosis. J Vasc Surg Venous Lymphat Disord. 2016;4:531–4. First citation in articleCrossref Medline, Google Scholar

  • 28 Kahn SR, Comerota AJ, Cushman M, Evans NS, Ginsberg JS, Goldenberg NA, et al. American Heart Association Council on Peripheral Vascular Disease, Council on Clinical Cardiology, and Council on Cardiovascular and Stroke Nursing: The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation. 2014;130:1636–61. First citation in articleCrossref Medline, Google Scholar

  • 29 Rattazzi M, Callegari E, Sponchiado A, Galliazzo S, Pagliara V, Villalta S, et al. Visceral obesity, but not metabolic syndrome, is associated with the presence of post-thrombotic syndrome. Thromb Res. 2015;136:225–8. First citation in articleCrossref Medline, Google Scholar

  • 30 Partsch H. Presence of varicose veins is the most important risk factor for developing PTS. Thromb Haemost. 2018;118:1130. First citation in articleCrossref Medline, Google Scholar

  • 31 Galanaud JP, Ducruet T, Kahn SR. on behalf of the SOX trial investigators group. Accuracy of contralateral Villalta score to assess for pre-existing chronic venous insufficiency in patients with unilateral deep vein thrombosis. J Thromb Haemost. 2020;Sep;8. https;//doi.org/10.1111/jth.15091. First citation in articleGoogle Scholar

  • 32 Kearon C, Kahn SR. Long-term treatment of venous thromboembolism. Blood. 2020;135:317–25. First citation in articleCrossref Medline, Google Scholar

  • 33 Rabinovich A, Kahn SR. Association between thrombophilia and the post-thrombotic syndrome. Int J Vasc Med. 2013;2013:643036. First citation in articleMedline, Google Scholar

  • 34 Rabinovich A, Cohen JM, Prandoni P, Kahn SR. Association between thrombophilia and the post-thrombotic syndrome: a systematic review and meta-analysis. J Thromb Haemost. 2014;12:14–23. First citation in articleCrossref Medline, Google Scholar

  • 35 Comerota J. What is postthrombotic venous obstruction and how can it be avoided? Phlebolymphology. 2016;23:76–80. First citation in articleGoogle Scholar

  • 36 Fahrni J, Engelberger RP, Kucher N, Willenberg T, Baumgartner I. Catheter-based treatment of ilio-femoral deep vein thrombosis – an update on current evidence. VASA. 2013;42:161–7. First citation in articleLink, Google Scholar

  • 37 Denny N, Musale S, Edlin H, Serracino-Inglott F, Thachil J. Iliofemoral deep vein thrombosis and the problem of post-thrombotic syndrome. Acute Med. 2018;17:99–103. First citation in articleMedline, Google Scholar

  • 38 Galanaud JP, Righini M, Le Collen L, Douillard A, Robert-Ebadi H, Pontal D, et al. Long-term risk of postthrombotic syndrome after symptomatic distal deep vein thrombosis: The CACTUS-PTS study. J Thromb Haemost. 2020;18:857–64. First citation in articleCrossref Medline, Google Scholar

  • 39 Kahn SR, Shrier I, Julian JA, Ducruet T, Arsenault L, Miron MJ, et al. Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med. 2008;149:698–707. First citation in articleCrossref Medline, Google Scholar

  • 40 Rabinovich A, Kahn SR. How to predict and diagnose postthrombotic syndrome. Pol Arch Med Wewn. 2014;124:410–6. First citation in articleMedline, Google Scholar

  • 41 Prandoni P, Lensing AW, Prins MH, Pesavento R, Piccioli A, Sartori MT, et al. The impact of residual thrombosis on the long-term outcome of patients with deep venous thrombosis treated with conventional anticoagulation. Semin Thromb Hemost. 2015;41:133–40. First citation in articleCrossref Medline, Google Scholar

  • 42 Prandoni P, Frulla M, Sartor D, Concolato A, Girolami A. Vein abnormalities and the post-thrombotic syndrome. J Thromb Haemost. 2005;3:401–2. First citation in articleCrossref Medline, Google Scholar

  • 43 Prandoni P, Lensing AW, Cogo A, Cuppini S, Villalta S, Carta M, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996;125:1–7. First citation in articleCrossref Medline, Google Scholar

  • 44 Bouman AC, Smits JJ, Ten Cate H, Ten Cate-Hoek AJ. Markers of coagulation, fibrinolysis and inflammation in relation to post-thrombotic syndrome. J Thromb Heamost. 2012;10:1532–8. First citation in articleCrossref Medline, Google Scholar

  • 45 Audu CO, Gordon AE, Obi AT, Wakefield TW, Henke PK. Inflammatory biomarkers in deep venous thrombosis organization, resolution, and post-thrombotic syndrome. J Vasc Surg Venous Lymphat Disord. 2020;8:299–305. First citation in articleCrossref Medline, Google Scholar

  • 46 Rabinovich A, Cohen JM, Kahn SR. The predictive value of markers of fibrinolysis and endothelial dysfunction in the post thrombotic syndrome. A systematic review. Thromb Haemost. 2014;111:1031–40. First citation in articleCrossref Medline, Google Scholar

  • 47 Rabinovich A, Cohen JM, Cushman M, Kahn SR, BioSOX Investigators. Association between inflammation biomarkers, anatomic extent of deep venous thrombosis, and venous symptoms after deep venous thrombosis. J Vasc Surg Venous Lymphat Disord. 2015;3(347–353):e1. First citation in articleMedline, Google Scholar

  • 48 Rabinovich A, Ducruet T, Kahn SR. Development of a clinical prediction model for the postthrombotic syndrome in a prospective cohort of patients with proximal deep vein thrombosis. J Thromb Haemost. 2018;16:262–70. First citation in articleCrossref Medline, Google Scholar

  • 49 Amin EE, van Kuijk SMJ, Joore MA, Prandoni P, Ten Cate H, Ten Cate-Hoek AJ, et al. Development and validation of a practical two-step prediction model and clinical risk score for post-thrombotic syndrome. Thromb Haemost. 2018;118:1242–9. First citation in articleCrossref Medline, Google Scholar

  • 50 Méan M, Limacher A, Alatri A, Aujesky D, Mazzolai L. Derivation and validation of a prediction model for risk stratification of post-thrombotic syndrome in elderly patients with a first deep vein thrombosis. Thromb Haemost. 2018;118:1419–27. First citation in articleCrossref Medline, Google Scholar

  • 51 Bradbury C, Fletcher K, Sun Y, Heneghan C, Gardiner C, Roalfe A, et al. A randomised controlled trial of extended anticoagulation treatment versus standard treatment for the prevention of recurrent venous thromboembolism (VTE) and post-thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (the ExACT study. Br J Haematol. 2020;188:962–75. First citation in articleMedline, Google Scholar

  • 52 Li R, Yuan M, Cheng J, Yu S, Wei W, Fu W, et al. Risk of post-thrombotic syndrome after deep vein thrombosis treated with rivaroxaban versus vitamin-K antagonists: A systematic review and meta-analysis. Thromb Res. 2020;196:340–8. First citation in articleCrossref Medline, Google Scholar

  • 53 Cheung W, Middeldorp S, Prins M, Pap A, Lensing A, ten Cate-Hoek J, et al. Post-thrombotic syndrome in patients treated with rivaroxaban or enoxaparin/vitamin K antagonists for acute deep-vein thrombosis. A post-hoc analysis. Thromb Heamost. 2016;116:733–8. First citation in articleCrossref Medline, Google Scholar

  • 54 Jeraj L, Jezovnik MK, Pl Poredos. Rivaroxaban versus warfarin in the prevention of post-thrombotic syndrome. Thromb Res. 2017;157:46–8. First citation in articleCrossref Medline, Google Scholar

  • 55 De Athayde Soares R, Matielo MF, Brochado Neto FC, Nogueira MP, Almeida RD, Sacilotto R. Comparison of the recanalization rate and postthrombotic syndrome in patients with deep venous thrombosis treated with rivaroxaban or warfarin. Surgery. 2019;166:1076–83. First citation in articleCrossref Medline, Google Scholar

  • 56 Hull R, Liang J, Towshed G. Long term low molecular weight heparin and the post thrombotic syndrome: a systemic review. Am J Med. 2011;124:756–65. First citation in articleCrossref Medline, Google Scholar

  • 57 Hull RD, Liang J, Merali T. Effect of long term LMWH on Post-thrombotic syndrome in patients with iliac/non iliac venous thrombosis. A subanalysis from HOME LITe studies. Clinical and Applied Thrombosis/Hemosis. 2013;19:476–81. First citation in articleCrossref Medline, Google Scholar

  • 58 Mulloy B, Hogwood J, Gray E, Lever R, Page CP. Pharmacology of heparin and related drugs. Pharmacol Rev. 2016;68:76–141. First citation in articleCrossref Medline, Google Scholar

  • 59 Poredos P, Poredos P, Jezovnik MK. Heparin promotes recanalization of venous thrombotic occlusions. Int Angiol. 2018;37:261–8. First citation in articleMedline, Google Scholar

  • 60 Andreozzi GM, Bignamini AA, Davì G, Palareti G, Matuška J, Holý M, et al. SURVET Study Investigators. Sulodexide for the Prevention of Recurrent Venous Thromboembolism: The Sulodexide in Secondary Prevention of Recurrent Deep Vein Thrombosis (SURVET) Study: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. Circulation. 2015;132:1891–7. First citation in articleCrossref Medline, Google Scholar

  • 61 Luzzi R, Belcaro G, Dugall M, Hu S, Arpaia G, Ledda A, Ippolito E, et al. The efficacy of sulodexide in the prevention of post-thrombotic syndrome. Clin App Thromb Heamost. 2014;20:594–9. First citation in articleCrossref Medline, Google Scholar

  • 62 Kessinger CW, Kim JW, Henke PK, Thompson B, McCarthy JR, Hara T, et al. Statins improve the resolution of established murine venous thrombosis: reductions in thrombus burden and vein wall scarring. PLoS ONE. 2015;10:e0116621. First citation in articleCrossref Medline, Google Scholar

  • 63 Hsu C, Brahmandam A, Brownson K, Huynh N, Reynolds J, Lee A, et al. Statin therapy associated with improved thrombus resolution in patients with deep vein thrombosis. J Vasc Sur Venous Lymphat Disord. 2019;7(169–175):e4. First citation in articleGoogle Scholar

  • 64 San Norberto EM, Gastambide MV, Taylor JH, García-Saiz I, Vaquero C. Efects of rosuvastatin as an adjuvant treatment for deep vein thrombosis. VASA. 2016;45:133–40. First citation in articleLink, Google Scholar

  • 65 Rabe E, Partsch H, Hafner J, Lattimer C, Mosti G, Neumann M, et al. Indications for medical compression stockings in venous and lymphatic disorders: An evidence-based consensus statement. Phlebology. 2018;33:163–84. First citation in articleCrossref Medline, Google Scholar

  • 66 Prandoni P, Lensing AW, Prins MH, Frulla M, Marchiori A, Bernardi E, et al. Below–knee elastic compression stocking to prevent the post-thrombotic syndrome. Ann Int Med. 2004;141(4):249–56. First citation in articleCrossref Medline, Google Scholar

  • 67 Blattler W, Partsch H. Leg compression and ambulation is better than bed rest for the treatment of acute deep venous thrombosis. Int Angiol. 2003;22:393–400. First citation in articleMedline, Google Scholar

  • 68 Kahn SR, Shapiro S, Wells PS, Rodger MA, Kovacs MJ, Anderson DR, et al. SOX trial investigators. Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial. Lancet. 2014;383:880–8. First citation in articleCrossref Medline, Google Scholar

  • 69 Appelen D, van Loo E, Prins MH, Neumann MHAM, Kolbach DN. Compression therapy for prevention of post-thrombotic syndrome (Review). Cochrane Database of Systematic Reviews. 2017;9:CD004174. First citation in articleMedline, Google Scholar

  • 70 Labropoulos N, Gasparis AP, Caprini JA, Partsch H. Compression stockings to prevent post-thrombotic syndrome. Lancet. 2014;384:129–30. First citation in articleCrossref Medline, Google Scholar

  • 71 Ten Cate-Hoek AJ, Amin EE, Bouman AC, Meijer K, Tick LW, Middeldorp S, et al. IDEAL DVT investigators. Individualised versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome (IDEAL DVT): a multicentre, randomised, single-blind, allocation-concealed, non-inferiority trial. Lancet Haematol. 2018;5:e25–e33. First citation in articleCrossref Medline, Google Scholar

  • 72 Amin EE, Bistervels IM, Meijer K, Tick LW, Middeldorp S, Mostard G, et al. Reduced incidence of vein occlusion and postthrombotic syndrome after immediate compression for deep vein thrombosis. Blood. 2018;132:2298–304. First citation in articleCrossref Medline, Google Scholar

  • 73 Meissner MH, Gloviczki P, Comerota AJ, Dalsing MC, Eklof BG, Gillespie DL, et al. Society for Vascular Surgery; American Venous Forum. Early thrombus removal strategies for acute deep venous thrombosis: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg. 2012;55:1449–62. First citation in articleCrossref Medline, Google Scholar

  • 74 Enden T, Haig Y, Kløw NE, Slagsvold CE, Sandvik L, Ghanima W, et al. CaVenT Study Group. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet. 2012;379:31–8. First citation in articleCrossref Medline, Google Scholar

  • 75 Haig Y, Enden T, Grøtta O, Kløw NE, Slagsvold CE, Ghanima W, et al. CaVenT Study Group. Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial. Lancet Haematol. 2016;3:e64–71. First citation in articleCrossref Medline, Google Scholar

  • 76 Vedantham S, Goldhaber SZ, Julian JA, Kahn SR, Jaff MR, Cohen DJ, et al. ATTRACT Trial Investigators. Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. N Engl J Med. 2017;377:2240–52. First citation in articleCrossref Medline, Google Scholar

  • 77 Notten P, Ten Cate-Hoek AJ, Arnoldussen CWKP, Strijkers RHW, de Smet AAEA, Tick LW, et al. Ultrasound-accelerated catheter-directed thrombolysis versus anticoagulation for the prevention of post-thrombotic syndrome (CAVA): a single-blind, multicentre, randomised trial. Lancet Haematol. 2020;7:e40–e49. First citation in articleCrossref Medline, Google Scholar

  • 78 Comerota AJ, Kearon C, Gu CS, Julian JA, Goldhaber SZ, Kahn SR, et al., ATTRACT Trial Investigators. Endovascular thrombus removal for acute iliofemoral deep vein thrombosis. Circulation. 2019;139:1162–73. First citation in articleCrossref Medline, Google Scholar

  • 79 Kahn S, Julian J, Kearon C, Gu Ch, Cohen D, Magnuson E, et al. Quality of life after pharmacomechanical catheter-directed thrombolysis for proximal deep venous thrombosis. J Vasc Surg Venous Lymphat Disord. 2020;8(8–23):e18. First citation in articleGoogle Scholar

  • 80 Notten P, Arnoldussen CWKP, Brans R, de Smet AAEA, Tick LW, van de Poel MHW, et al. Association of successful ultrasound-accelerated catheter-directed thrombolysis with postthrombotic syndrome: A post hoc analysis of the CAVA trial. Thromb Haemost. 2020;120:1188–99. First citation in articleCrossref Medline, Google Scholar

  • 81 Foegha P, Jensen LP, Klitfod L, Broholm R, Bækgaard N. Factors associated with long-term outcome in 191 patients with ilio-femoral DVT treated with catheter-directed thrombolysis. Eur J Vasc Endovasc Surg. 2017;53:419–424. First citation in articleCrossref Medline, Google Scholar

  • 82 Engelberger RP, Spirk D, Willenberg T, Alatri A, Do DD, Baumgartner I, et al. Ultrasound-assisted versus conventional catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis. Circ Cardiovasc Interv. 2015;8:e002027. First citation in articleCrossref Medline, Google Scholar

  • 83 Engelberger RP, Stuck A, Spirk D, Willenberg T, Haine A, Périard D, et al. Ultrasound-assisted versus conventional catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis: 1-year follow-up data of a randomized-controlled trial. J Thromb Haemost. 2017;15:1351–60. First citation in articleCrossref Medline, Google Scholar